UPDATE: JPMorgan Assumes Lumentum (LITE) at Neutral
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Lumentum (LITE) PT Lowered to $90 at Craig-Hallum
May 13, 2021 9:15 AM EDTCraig-Hallum analyst Richard Shannon lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $120.00) while maintaining a Buy rating.... More
Lumentum (LITE) PT Lowered to $90 at Northland Capital Markets
May 13, 2021 8:39 AM EDTNorthland Capital Markets analyst Tim Savageaux lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $130.00) while maintaining a Outperform rating.... More
Lumentum (LITE) PT Lowered to $90 at Jefferies for 3 Reasons
May 13, 2021 8:38 AM EDTJefferies analyst George Notter lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $115.00) after the earnings call revealed that 3D Sensing business economics are not as positive as previously believed resulting in three problems:
1) The company is losing more share than... More
Lumentum (LITE) PT Lowered to $87 at Needham & Company
May 13, 2021 6:45 AM EDTNeedham & Company analyst Alex Henderson lowered the price target on Lumentum (NASDAQ: LITE) to $87.00 (from $123.00) while maintaining a Buy rating.
The analyst commented, "Lumentum's print and guidance has unwound a lot of Revenue and earnings momentum, which in turn inhibits the valuation argument. From... More
UPDATE: Morgan Stanley Downgrades Lumentum (LITE) to Equalweight
May 13, 2021 2:16 AM EDT(Updated - May 13, 2021 5:05 AM EDT)
Morgan Stanley analyst Meta Marshall downgraded Lumentum (NASDAQ: LITE) from Overweight to Equalweight with a price target of $81.00 (from $105.00).
THe analyst comments "LITE reported in-line FQ3 (incl def rev from delayed 5G deployments in... More
Lumentum (LITE) PT Lowered to $87 at Stifel
May 12, 2021 5:54 PM EDTStifel analyst John Marchetti lowered the price target on Lumentum (NASDAQ: LITE) to $87.00 (from $98.00) while maintaining a Hold rating.
... MoreLumentum (LITE) PT Lowered to $90 at Susquehanna
May 12, 2021 4:59 PM EDTSusquehanna analyst Christopher Rolland lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $120.00) while maintaining a Positive rating.
... MorePre-Open Stock Movers 05/12: (LHDX) (UPST) (EYES) Higher; (ARRY) (CURI) (LMND) Lower (more...)
May 12, 2021 9:26 AM EDTToday's Pre-Open Movers:
Lucira Health, Inc. (Nasdaq: LHDX) 40.9% HIGHER; announced that its LUCIRA CHECK IT COVID-19 test kit is now available on Amazon.com in the US. Each LUCIRA CHECK IT test kit provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text based digital LUCI PASS verified test result on their... More
Lumentum Holdings (LITE) Reports In-Line Q3 EPS, Revenues Miss; Offers 4Q EPS/Revenues Guidance Below Consensus
May 12, 2021 7:34 AM EDTLumentum Holdings (NASDAQ: LITE) reported Q3 EPS of $1.40, in-line with the analyst estimate of $1.40. Revenue for the quarter came in at $419.5 million versus the consensus estimate of $433.49 million.
"The strong year on year margin improvements in our third quarter results highlight a product portfolio increasingly rich in new and differentiated products that are aligned with multi-year favorable market trends and the impact of continuous improvement in our... More